Home > Financial Ratios > WINDLAS BIOTECH

WINDLAS BIOTECH
Working Capital/Sales

    Back to All Ratios
AD     Remove this Ad

WINDLAS BIOTECH Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 2.762.432.211.624.24

What is the latest Working Capital/Sales ratio of WINDLAS BIOTECH ?

The latest Working Capital/Sales ratio of WINDLAS BIOTECH is 2.76 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20252.76
Mar20242.43
Mar20232.21
Mar20221.62
Mar20214.24

How is Working Capital/Sales of WINDLAS BIOTECH Trending?

Years Working Capital/Sales % Change
Mar2025 2.76
13.58
Mar2024 2.43
9.95
Mar2023 2.21
36.42
Mar2022 1.62
-61.79
Mar2021 4.24 -

Other Financial Ratios of WINDLAS BIOTECH


Compare Working Capital/Sales ratio of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,615.1 Cr 5.3% 0.4% -15.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,837.0 Cr 1% 3.8% 0.6% Stock Analytics
DIVIS LABORATORIES ₹159,175.0 Cr -1.7% -4.1% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,394.0 Cr -0% -3% 33.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,999.0 Cr -1.3% -1.3% 8.6% Stock Analytics
CIPLA ₹100,379.0 Cr -1.1% -6.3% -18.3% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

5.3%

0.4%

-15.5%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses